Industry News
Dual Kinase Inhibitor Shows Early Promise in Multiple Cancers
CYC065, an inhibitor of CDK2 and CDK9 kinases, has inhibited tumor growth in some patients with advanced cancers
News & Articles
25
CYC065, an inhibitor of CDK2 and CDK9 kinases, has inhibited tumor growth in some patients with advanced cancers